Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Developmental milestones

Prevention or amelioration of disease complications including adverse psychological effects on the patient and caregivers or delay in developmental milestones... [Pg.814]

Intrauterine seizures may occur. The electroencephalogram often displays a hypsarrhythmia or a burst-suppression pattern. Patients display myoclonic jerks, hiccuping and a profound hypotonia. The few patients who survive past the first week usually sustain profound mental retardation and neurological disability. Brain imaging shows atrophy and a loss of myelin. Rarely, patients present later in life with psychomotor retardation and growth failure. Others have had initial normal development followed by a progressive loss of developmental milestones. Some patients have manifested spinocerebellar degeneration and other symptoms of motor dysfunction [27],... [Pg.674]

Developmental Milestones of the Human and Mouse Immune System... [Pg.329]

Additional developmental milestones for FPOP include the demonstration of fCd determination and development of dose-dependent radical foot printing by using different scavengers and concentrations to vary and then quantify the loss of unmodified peptide signal and the increase of modified peptide. Further advances can be made by determining with certainty the reaction timescale. At the... [Pg.366]

Developmental milestones Such as the days of incisor eruption, fur growth, and eye opening. [Pg.85]

With full recognition that we still have far to travel, the appearance of this volume documents the fact that pediatric psychopharmacology has reached its own important developmental milestone. What is contained in this volume and the implied promise it holds for the future will be of enormous benefit to children and families. [Pg.799]

The second prospective study of in utero exposure to methylmercury was initiated in the Republic of Seychelles and enrolled about 800 mother-infant pairs (Myers et al., 1995). In contrast to the Faroe Islands study, the investigation in the Seychelles did not find evidence of methylmercury-related adverse effects on the neuro-behavioural development of children through nine years of age (Myers et al., 2003). In some instances, prenatal mercury exposure was actually associated with precocious behaviour, and important developmental milestones were reached more quickly in the most highly exposed subjects. [Pg.73]

During the 3 months following their birth, both sisters sustained recurrent upper respiratory illnesses. These were more severe in Elizabeth, who required frequent hospitalizations. Physical examination of both infants during this period disclosed poor feeding habits, failure to thrive, floppiness, microcephaly (small head size), and delayed developmental milestones. They were below the fifth percentile for weight and height. These findings were more pro-... [Pg.77]

The child had had a normal and uneventful prenatal and birth history. He was born after a full-term gestation and weighed 3 3 kg. Until a few days prior to the incident, he had no medical problems. His weight, length, and head circumference had always followed the 40th percentile on growth charts. He had attained normal developmental milestones for age.There was no known consanguinity between the parents and no family history of similar problems, and there was a normal 3-year-old brother. [Pg.134]

If the child with profound biotinidase deficiency is symptomatic, then the biochemical abnormalities and seizures resolve rapidly after biotin treatment. This is usually followed by improvement of the cutaneous abnormalities. Hair growth returns over a period of weeks to months in the children with alopecia. Optic atrophy and hearing loss are usually resistant to therapy, especially if several months have elapsed between the time of diagnosis and the initiation of treatment. Some treated children have rapidly regained lost developmental milestones, whereas others have continued to show deficits. [Pg.142]

The clinical course of PKU is progressive and exhibits considerable variability among individuals. Mental retardation is the hallmark of the disease in untreated patients, but other neurological manifestations are often present (Table 19-1). Newborns initially appear normal but fail to attain early developmental milestones, including failure to roll by 4 months, failure to sit by 6... [Pg.205]

The transfer to milk of risperidone and its active metabolite 9-hydroxyrisperidone has been examined in two breast-feeding women and in one woman with risperidone-induced galactorrhea (209). The milkrplasma concentration ratio was under 0.5 for both compounds the calculated relative infant doses were 2.3%, 2.8%, and 4.7% of that of women s weight-adjusted doses neither compound was detected in the plasma of the two babies, who achieved their developmental milestones satisfactorily and did not have any adverse effect attributable to risperidone. The authors concluded that maternal risperidone therapy is unlikely to pose a significant hazard to the breast-fed infant in the short term, and recommended an individual benefit-harm analysis to take decisions about this issue. [Pg.348]

Unusual manifestations of neurological toxicity of phenobarbital include regression of developmental milestones mimicking a neurodegenerative disorder in young children (SEDA-19, 72) and unilateral choreiform hyperkinesia as a possible withdrawal symptom (SEDA-22, 82). [Pg.2798]

Myers et al. (1997) evaluated the population of the SCDS for developmental milestones similar to those determined in Iraq. As part of this ongoing study, cohort children were evaluated at 6.5, 19, 29, and 66 months of age. At 19 months care-givers were asked at what age the child walked (n=720 out of 738) and talked (n=680). Prenatal mercury exposure was determined by atomic absorption analysis of maternal hair segments corresponding to hair growth during the pregnancy. [Pg.165]

Myers GJ, Davidson PW, Shamlaye CF, et al. 1997. Effects of prenatal methylmercury exposure from a high fish diet on developmental milestones in the Seychelles child development study. Neurotoxicol 18(3) 819-29. [Pg.631]


See other pages where Developmental milestones is mentioned: [Pg.107]    [Pg.285]    [Pg.550]    [Pg.813]    [Pg.105]    [Pg.106]    [Pg.351]    [Pg.424]    [Pg.495]    [Pg.523]    [Pg.469]    [Pg.236]    [Pg.51]    [Pg.75]    [Pg.194]    [Pg.196]    [Pg.89]    [Pg.45]    [Pg.228]    [Pg.264]    [Pg.151]    [Pg.1401]    [Pg.89]    [Pg.38]    [Pg.89]    [Pg.163]    [Pg.165]    [Pg.266]    [Pg.274]    [Pg.275]    [Pg.275]    [Pg.336]    [Pg.678]   
See also in sourсe #XX -- [ Pg.85 , Pg.424 , Pg.495 ]

See also in sourсe #XX -- [ Pg.106 ]




SEARCH



Milestone

Milestoning

© 2024 chempedia.info